149 related articles for article (PubMed ID: 37216303)
1. Immunohistochemical expression of BCL-2 in hydatidiform moles: a tissue microarray study.
Al-Jabri M; Al-Badi S; Al-Kindi H; Arafa M
Pathologica; 2023 May; 1(1):148-154. PubMed ID: 37216303
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21
Missaoui N; Landolsi H; Mestiri S; Essakly A; Abdessayed N; Hmissa S; Mokni M; Yacoubi MT
Pathol Res Pract; 2019 Mar; 215(3):446-452. PubMed ID: 30558966
[TBL] [Abstract][Full Text] [Related]
3. P57
Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis.
Memtsa M; Johns J; Jurkovic D; Ross JA; Sebire NJ; Jauniaux E
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():206-212. PubMed ID: 32877774
[TBL] [Abstract][Full Text] [Related]
5. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
Wong SY; Ngan HY; Chan CC; Cheung AN
Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Androgenetic Complete Hydatidiform Moles with p57
Li MW; Li F; Cheng J; Wang F; Zhou P
Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
10. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
11. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
12. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
13. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
14. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
15. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole.
Qiao S; Nagasaka T; Harada T; Nakashima N
Placenta; 1998; 19(5-6):361-9. PubMed ID: 9699956
[TBL] [Abstract][Full Text] [Related]
16. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
Sebire NJ
Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.
Vang R; Gupta M; Wu LS; Yemelyanova AV; Kurman RJ; Murphy KM; Descipio C; Ronnett BM
Am J Surg Pathol; 2012 Mar; 36(3):443-53. PubMed ID: 22245958
[TBL] [Abstract][Full Text] [Related]
18. Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes.
Zainal N; Kampan NC; Rose IM; Ghazali R; Shafiee MN; Yussoff NH; Tamil A; Jamil MA; Hussin NH
Horm Mol Biol Clin Investig; 2021 May; 42(3):311-316. PubMed ID: 34018382
[TBL] [Abstract][Full Text] [Related]
19. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis.
Cheung AN; Khoo US; Lai CY; Chan KY; Xue WC; Cheng DK; Chiu PM; Tsao SW; Ngan HY
Cancer; 2004 Apr; 100(7):1411-7. PubMed ID: 15042675
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
